A review of Plks: Thinking outside the (polo) box
Citations Over TimeTop 14% of 2022 papers
Abstract
The polo-like kinase (Plk) family is comprised of five different members (Plk1-5), each with their own distinct functions. Plk family members participate in pivotal cell division processes as well as in non-mitotic roles. Importantly, Plk expression has been correlated with various disease states, including cancer. Multiples therapies, which primarily target Plk1, are currently being investigated alone or in combination with other agents for clinical use in different cancers. As the role of Plks in disease progression becomes more prominent, it is important to outline their functions as cell cycle regulators and more. This review summarizes the structure and both mitotic and non-mitotic functions of each of the five Plk family members, sequentially. Additionally, the proposed mechanisms for how Plks contribute to tumorigenesis and the therapeutics currently under investigation are outlined.
Related Papers
- → Bimodal Interaction of Mammalian Polo-Like Kinase 1 and a Centrosomal Scaffold, Cep192, in the Regulation of Bipolar Spindle Formation(2015)56 cited
- → Progress in the Discovery of Polo-like Kinase Inhibitors(2005)111 cited
- → Centrosomal protein FOR20 is essential for S-phase progression by recruiting Plk1 to centrosomes(2013)33 cited
- → A review of Plks: Thinking outside the (polo) box(2022)20 cited
- Preclinical Research and Early Clinical Research of Polo-like Kinase 1 Inhibitors(2011)